Sign in

CIK 0001837607 · <br>Emerging growth company

AEON Biopharma, Inc.

Sign in to watch
Ticker
AEON
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
853940478
Phone
(949) 354-6499
Business address
130 VANTIS DRIVE, SUITE 170, ALISO VIEJO, CA, 92656
Former names
Priveterra Acquisition Corp.
  1. 424B5 Offering Prospectus
  2. 8-K Event Regulation FD disclosure
  3. 424B5 Offering Prospectus
  4. 8-K Event Bylaws or fiscal year change
  5. SC 13G Stake Amended Statement of Ownership
  6. 424B3 Offering Prospectus
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 8-K Event Regulation FD disclosure
  10. 4/A Grant or award Director acquired 36,021 shares (grant or award)
  11. 4 Grant or award CHIEF EXECTUIVE OFFICER acquired 470,692 shares (grant or award)
  12. 4 Grant or award EXEC VP, CLO & CORP SECRETARY acquired 180,110 shares (grant or award)
  13. 4 Grant or award Director acquired 36,021 shares (grant or award)
  14. 4 Grant or award CHIEF MEDICAL OFFICER acquired 192,117 shares (grant or award)
  15. 4 Grant or award PRINCIPAL ACCOUNTING OFFICER acquired 18,010 shares (grant or award)
  16. 4 Grant or award Director acquired 36,021 shares (grant or award)
  17. 4 Grant or award Director acquired 36,021 shares (grant or award)
  18. 4 Grant or award Director acquired 36,021 shares (grant or award)
  19. EFFECT Other Notice of Effectiveness
  20. 424B5 Offering Prospectus

Page 7 of 19 · 363 filings